ASF1B and cutaneous melanoma: We also found that ASF1B expression levels varied significantly among different clinical stages in patients with Adrenocortical carcinoma (ACC), Breast invasive carcinoma (BRCA), Colon adenocarcinoma (COAD), Kidney Chromophobe (KICH), Kidney renal clear cell carcinoma (KIRC), Kidney renal papillary cell carcinoma (KIRP), Liver hepatocellular carcinoma (LIHC), LUAD, Lung squamous cell carcinoma (LUSC) and Skin Cutaneous Melanoma (SKCM) (Figure 1C).